Inventor

Karla Drescher

Inventor

Ludwigshafen, DE

Overview

2000–2019

Patent span

Human necessities

Primary field (CPC A)

Patents· 52 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds43%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations39%

A61KPreparations for medical, dental or toiletry purposes16%

C07CAcyclic or carbocyclic compounds2%

PatentTitleYear

10,308,610Inhibitor compounds of phosphodiesterase type 10A2019 10,118,926Tricyclic quinoline and quinoxaline derivatives2018 9,994,568Tricyclic quinoline and quinoxaline derivatives2018 9,938,269Inhibitor compounds of phosphodiesterase type 10A2018 9,856,220'Inhibitor compounds of phosphodiesterase type 10A'2018 9,790,203'Inhibitor compounds of phosphodiesterase type 10A'2017 9,657,034'Substituted furo[3,2-c]pyridines, thieno[3,2-c]pyridines, thieno[2,3-d]pyridazines and pyrido[3,4-d]pyridazines as phosphodiesterase type 10A inhibitors'2017 9,573,950'Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulators'2017 9,540,376'Hexahydrodiazepinoquinolines carrying a substituted alkyl radical'2017 9,475,808'Inhibitor compounds of phosphodiesterase type 10A'2016 9,464,072'Treatment of central nervous system disorders'2016 9,464,085'Inhibitor compounds of phosphodiesterase type 10A'2016 9,388,141'Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor'2016 9,388,148'Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor'2016 9,388,180'Inhibitor compounds of phosphodiesterase type 10A'2016 9,376,396'Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor'2016 9,273,068'Substituted isoquinolines and phthalazines as inhibitors of phosphodiesterase type 10A'2016 9,200,005'Inhibitor compounds of phosphodiesterase type 10A'2015 9,169,253'Tricyclic quinoline and quinoxaline derivatives'2015 9,163,019'Inhibitor compounds of phosphodiesterase type 10A'2015 8,969,552'Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2015 8,940,902'Treatment of central nervous system disorders'2015 8,642,642'Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor'2014 8,507,469'Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor'2013 8,497,273'Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor'2013 8,492,540'1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2013 8,486,984'Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2013 8,476,275'N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine D3 receptor'2013 8,470,810'Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2013 8,440,694'Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor'2013 8,383,641'Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2013 8,362,010'Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor'2013 8,343,959'N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor'2013 8,293,913'Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor'2012 8,242,102'Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor'2012 8,232,426'Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2012 8,207,160'Tetrahydrobenzazepines and their use in he modulation of the dopamine D3 receptor'2012 8,202,868'4-piperazinyl-pyrimidine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2012 8,183,237'Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor'2012 8,101,754'Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2012 8,076,326'N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor'2011 7,851,463'Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2010 7,834,048'Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2010 7,790,727'Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor'2010 7,759,397'6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2010 7,320,979'N-[(piperazinyl)hetaryl]arylsulfonamide compounds'2008 7,026,311'Dibenzodiazepine derivatives, their preparation and use'2006 6,919,342'Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2005 6,444,674'Substituted pyrimidine compounds and the use thereof'2002 6,403,593'Triazole compounds and the use thereof'2002 6,342,604'Substitute pyrimidine compounds and the use thereof'2002 6,124,294'Triazole compounds and the use thereof'2000

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2000–2016Based in Dossenheim, DE· patent location history

2005–2016Patents assigned to ABBOTT GMBH & CO KG (27)· patent assignee history

2011–2018Patents assigned to DRESCHER KARLA (22)· patent assignee history

2011–2015Patents assigned to HAUPT ANDREAS (20)· patent assignee history

2011–2015Patents assigned to UNGER LILIANE (20)· patent assignee history

2011–2019Based in Ludwigshafen, DE· patent location history

2014–2019Patents assigned to ABBVIE DEUTSCHLAND (20)· patent assignee history

2017Based in Wiesbaden, DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
ABBOTT GMBH & CO KG	27	2005–2016
DRESCHER KARLAself	22	2011–2018
ABBVIE DEUTSCHLAND	20	2014–2019
HAUPT ANDREAS	20	2011–2015
UNGER LILIANE	20	2011–2015

Locations

Location	Patents	Span
Ludwigshafen, DE	27	2011–2019
Dossenheim, DE	24	2000–2016
Wiesbaden, DE	1	2017